8
2
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T63812 |
MrgprX2 antagonist-8
|
Others | Others |
MrgprX2 antagonist-8 是 MrgprX2 拮抗剂,能够用于研究炎症性疾病。 | |||
T63766 | MrgprX2 antagonist-7 | ||
MrgprX2 antagonist-7 是一种抗过敏剂,具有明显的抗过敏效果,能够抑制肥大细胞脱颗粒。 | |||
T40176 |
MrgprX2 antagonist-5
MrgprX2 antagonist-5 |
||
MrgprX2 antagonist-5, which acts as a potent antagonist of MrgprX2. It exhibits the ability to effectively inhibit the activity of MrgprX2, making it an ideal candidate for research related to inflammatory skin disorders. | |||
T40268 |
MrgprX2 antagonist-4
MrgprX2 antagonist-4 |
||
MrgprX2 antagonist-4 and compound B-51 E117, is a potent MrgprX2 antagonist. It specifically targets and inhibits the MrgprX2 receptor, making it suitable for investigating various inflammatory skin disorders. | |||
T40270 |
MrgprX2 antagonist-1
MrgprX2 antagonist-1 |
||
MrgprX2 antagonist-1, is a novel MrgprX2 antagonist compound. It exhibits potential for exploration in studying cutaneous inflammatory disorders. | |||
T40273 |
MrgprX2 antagonist-2
MrgprX2 antagonist-2 |
||
MrgprX2 antagonist-2 is a potent antagonist of MrgprX2. It holds potential for investigating skin inflammatory disorders. | |||
T40271 |
MrgprX2 antagonist-3
MrgprX2 antagonist-3 |
||
MrgprX2 antagonist-3 is a potent inhibitor of MrgprX2. It holds promising potential for investigating skin inflammatory disorders. | |||
T63394 | MrgprX2 antagonist-6 | ||
MrgprX2 antagonist-6 是一种高效抗过敏剂,对肥大细胞脱颗粒具有抑制作用。 |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-02200 |
Peroxiredoxin 2 Protein, Human, Recombinant (His)
PRP,HEL-S-2a,TSA,NKEF-B,TDPX1,PTX1,TPX1,peroxiredox... |
Human | Baculovirus Insect Cells |
Peroxiredoxin 2 Protein, Human, Recombinant (His) is expressed in Baculovirus insect cells with His tag. The predicted molecular weight is 24 kDa and the accession number is P32119. | |||
TMPH-01640 |
MRGPRX2 Protein, Human, Recombinant (His)
|
Human | E. coli |
Mast cell-specific receptor for basic secretagogues, i.e. cationic amphiphilic drugs, as well as endo- or exogenous peptides, consisting of a basic head group and a hydrophobic core. Recognizes and binds small molecules containing a cyclized tetrahydroisoquinoline (THIQ), such as non-steroidal neuromuscular blocking drugs (NMBDs), including tubocurarine and atracurium. In response to these compounds, mediates pseudo-allergic reactions characterized by histamine release, inflammation and airway c... |